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Down syndrome (mongolism) is one of the commonest chromosomal abnor-
malities in man with an incidence of between 1 and 2 per 1000 live births. In
Northern Ireland the incidence is 1 in 6301. About 95 per cent have 47 instead
of 46 chromosomes with an extra chromosome 21 (Trisomy 21). A small pro-
portion, between 2 and 5 per cent are due to an unbalanced chromosomal
translocation, usually involving the D(13-15) group chromosomes, particularly
chr( nosomes 14 and 21. About half of the cases of translocation Down syndrome
are inherited and thus, other family relatives may carry the chromosomal
translocation and have a high risk of having affected children. The purpose of
this paper is to describe our recent experience with a family which illustrates
the importance of cytogenetic examination in all Down syndrome infants, of
family follow-up when an unbalanced translocation is discovered, and of
providing genetic counselling for those relatives who are carriers.
PATIENTS
CASE 1. The propositus (Fig. 1. IV.1), a female, born 11 April 1980, was the
FIG. t. Pedigree of the families.
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14/21 CARRIER _ _ OFFSPRINGfirst born of a 27 year-old mother and a 28 year-old father. Birthweight was
3203 gms. at 38 weeks gestation. Clinical examination revealed the typical facial
appearance of Down syndrome. Cytogenetic studies showed an unbalanced
translocation, 46,XX,-14,t(14: 21) (Fig 2). Blood from the parents revealed that
the mother was a balanced translocation (45,XX,t(14: 21) (Fig. 3).
FIG. 2. Karyotype of the unbalanced translocation. Arrow indicates the
translocation (t(14214a)).
FIG. 3 Karyotypeof the balanced translocation. Arrow inr
translocation (t(14a21q)).
96CASE 2. A female (Fig. 1. IV.19), born 7 July 1980, was the first born of a 24
year-old mother and a 28 year-old father. Birthweight was 3175 gms. at 40
weeks gestation. The baby had the typical facial appearance of Down syndrome.
Cytogenetic studies showed an unbalanced translocation (46,XX-14t(14: 21).
Blood from the parents demonstrated that the mother had a balanced trans-
location (45,XX,t(14: 21). The mothers of Case I and Case 2 were paternal first
cousins.
Relatives of the families- were visited and blood samples obtained for cyto-
genetic examination in a total of 21 other relatives. Apart from the above two
Down syndrome infants (Case I and Case 2) no other relative was affected.
RESULTS
There was no difficulty in persuading the relatives to provide a blood sample
for chromosome analysis once the situation had been carefully explained. Of the
21 relatives examined, 8 (7 males and 1 female) were discovered to have a
bala-iced 14/21 translocation. Of the 10 balanced translocation carriers in the
family, 7 had children. Three female balanced translocation parents produced a
total of 6 children; 2 normal infants, 2 with balanced translocations, and 2 with
Down syndrome. The four male balanced carrier parents produced a total of 15
children; 9 normal infants, 5 with balanced translocations, and one unknown
(died in infancy).
DISCUSSION
The incidence of Down syndrome is between I and 2 per 1000 live births. Over
95 per cent of cases are caused by non-disjunction, the remainder resulting from
translocation2. Down syndrome due to translocation can only be distinguished
from that due to Trisomy 21 by cytogenetic examination. Our family illustrates
the importance of cytogenetic examination in all Down syndrome newborn and
of follow-up of the relatives when an unbalanced translocation is found. Among
cases of unbalanced translocation Down syndrome about half are inherited.
When inherited, the risk of maternal carriers of a 14/21 translocation producing
an infant with Down syndrome is approximately 10 per cent and about 2-3 per
cent when the father is the carrier3. Similar risks are involved when the trans-
location involves chromosomes 21 and 22. However, if either parent has a
balanced 21/21 translocation all pregnancies will be abnormal since the only
alternatives are the unbalanced translocation Down syndrome and the lethal
monosomy 21. Our family also emphasises that the risk of Down syndrome
offspring is greater when the mother carries the translocation. Both Down
syndrome infants had been born to females with balanced 14/21 translocations.
The four males with balanced 14/21 translocations had a total of 15 children, of
whom 9 had normal chromosome constitutions, 5 had balanced 14/21 trans-
locations, and one was unknown (died in infancy). When individuals in this
family had been identified as having balanced translocations, they were advised
of the risk of having an infant with the Down syndrome and of the availability
of prenatal diagnosis by cytogenetic examination of cultured amniotic fluid
cells in any future pregnancy.
97SUMMARY
The finding of an unbalanced translocation t(14q21q) in two Down syndrome
infants, born within three months of each other to mothers who were paternal
first cousins, led to a clinical and cytogenetic investigation of the families.
Chromosome examination in 25 individuals revealed 10 balanced translocation
carriers, 3 females and 7 males. Both Down syndrome babies had been born to
balanced female carriers. The study emphasises the importance of chromosome
examination in all Down syndrome infants, and in relatives when an unbalanced
chromosome constitution is discovered.
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